These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 3024653)

  • 1. Species difference in the specific receptors of platelet activating factor.
    Hwang SB; Lam MH
    Biochem Pharmacol; 1986 Dec; 35(24):4511-8. PubMed ID: 3024653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific binding of [3H]dihydrokadsurenone to rabbit platelet membranes and its inhibition by the receptor agonists and antagonists of platelet-activating factor.
    Hwang SB; Lam MH; Chang MN
    J Biol Chem; 1986 Oct; 261(29):13720-6. PubMed ID: 3020044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets.
    Robaut C; Durand G; James C; Lave D; Sedivy P; Floch A; Mondot S; Pacot D; Cavero I; Le Fur G
    Biochem Pharmacol; 1987 Oct; 36(19):3221-9. PubMed ID: 2822048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor.
    Hwang SB; Lam MH; Biftu T; Beattie TR; Shen TY
    J Biol Chem; 1985 Dec; 260(29):15639-45. PubMed ID: 2999126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species-dependent differences of high affinity [3H]PAF-binding to platelets from humans and pigs and its inhibition by selected antagonists.
    Ostermann G; Lorenz A; Hofmann B; Kertscher HP
    J Lipid Mediat; 1991 Nov; 4(3):289-98. PubMed ID: 1662546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists.
    Domingo MT; Piro F; Broquet C; Auclair E; Chabrier PE; Braquet P
    Lipids; 1992 Aug; 27(8):582-6. PubMed ID: 1328798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic characterization of the rabbit neutrophil receptor for platelet-activating factor.
    Paulson SK; Wolf JL; Novotney-Barry A; Cox CP
    Proc Soc Exp Biol Med; 1990 Nov; 195(2):247-54. PubMed ID: 2172997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
    Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J
    Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet.
    Terashita Z; Imura Y; Nishikawa K
    Biochem Pharmacol; 1985 May; 34(9):1491-5. PubMed ID: 2986648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes.
    Hwang SB
    J Biol Chem; 1988 Mar; 263(7):3225-33. PubMed ID: 2830276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
    Baroggi N; Etienne A; Braquet P
    Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages.
    Stewart AG; Dusting GJ
    Br J Pharmacol; 1988 Aug; 94(4):1225-33. PubMed ID: 2850058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021.
    Lachachi H; Plantavid M; Simon MF; Chap H; Braquet P; Douste-Blazy L
    Biochem Biophys Res Commun; 1985 Oct; 132(2):460-6. PubMed ID: 2998370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of platelet activating factor-induced chemiluminescence in guinea-pig peritoneal macrophages in differing states of activation.
    Parnham MJ; Bittner C; Lambrecht G
    Br J Pharmacol; 1989 Oct; 98(2):574-80. PubMed ID: 2819335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAF-receptor. 1. 'Cache-oreilles' effect of selected high-potency platelet-activating factor (PAF) antagonists.
    Dive G; Godfroid JJ; Lamotte-Brasseur J; Batt JP; Heymans F; Dupont L; Braquet P
    J Lipid Mediat; 1989; 1(4):201-15. PubMed ID: 2562434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba.
    Lamant V; Mauco G; Braquet P; Chap H; Douste-Blazy L
    Biochem Pharmacol; 1987 Sep; 36(17):2749-52. PubMed ID: 2820421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.
    Shen TY; Hwang SB; Chang MN; Doebber TW; Lam MH; Wu MS; Wang X; Han GQ; Li RZ
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):672-6. PubMed ID: 2983307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of kadsurenone analogues.
    Ponpipom MM; Bugianesi RL; Brooker DR; Yue BZ; Hwang SB; Shen TY
    J Med Chem; 1987 Jan; 30(1):136-42. PubMed ID: 3027330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor.
    Shen TY; Hwang SB; Chang MN; Doebber TW; Lam MH; Wu MS; Wang X
    Int J Tissue React; 1985; 7(5):339-43. PubMed ID: 2997065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
    Tahraoui L; Floch A; Cavero I
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.